| 1 |
30386953 | Extracellular vesicles of multiple myeloma cells utilize the proteasome inhibitor mechanism to moderate endothelial angiogenesis. | 2019 Feb |
1 |
| 2 |
29693175 | Microvesicles shed from bortezomib-treated or lenalidomide-treated human myeloma cells inhibit angiogenesis in vitro. | 2018 Jun |
2 |
| 3 |
28161489 | Antiproliferative effects of Bortezomib in endothelial cells transformed by viral G protein-coupled receptor associated to Kaposi's sarcoma. | 2017 Apr |
2 |
| 4 |
27080362 | Bortezomib sensitizes esophageal squamous cancer cells to radiotherapy by suppressing the expression of HIF-1α and apoptosis proteins. | 2016 Apr 13 |
1 |
| 5 |
25370780 | A quantitative microfluidic angiogenesis screen for studying anti-angiogenic therapeutic drugs. | 2015 Jan 7 |
2 |
| 6 |
24333736 | Capillarisin inhibits constitutive and inducible STAT3 activation through induction of SHP-1 and SHP-2 tyrosine phosphatases. | 2014 Apr 1 |
1 |
| 7 |
24380732 | Protective role of bortezomib in steatotic liver ischemia/reperfusion injury through abrogation of MMP activation and YKL-40 expression. | 2014 Mar |
1 |
| 8 |
24093630 | Proteasome inhibition with bortezomib induces cell death in GBM stem-like cells and temozolomide-resistant glioma cell lines, but stimulates GBM stem-like cells' VEGF production and angiogenesis. | 2013 Dec |
1 |
| 9 |
21909688 | Bortezomib represses HIF-1α protein expression and nuclear accumulation by inhibiting both PI3K/Akt/TOR and MAPK pathways in prostate cancer cells. | 2012 Jan |
1 |
| 10 |
22324515 | Bortezomib reverses the proliferative and antiapoptotic effect of neuropeptides on prostate cancer cells. | 2012 Jun |
1 |
| 11 |
22477151 | Combined inhibition of cellular pathways as a future therapeutic option in fatal anaplastic thyroid cancer. | 2012 Dec |
1 |
| 12 |
22488443 | Efficacy of lenalidomide plus dexamethasone for POEMS syndrome relapsed after autologous peripheral stem-cell transplantation. | 2012 Jun |
1 |
| 13 |
23013101 | Bortezomib inhibits the angiogenesis mediated by mesenchymal stem cells. | 2012 Nov |
2 |
| 14 |
19914061 | Bortezomib and zoledronic acid on angiogenic and vasculogenic activities of bone marrow macrophages in patients with multiple myeloma. | 2010 Jan |
2 |
| 15 |
20561442 | [Effect of bortezomib on VEGF gene expression of endothelial cell line HMEC-1 and its possible mechanisms]. | 2010 Jun |
4 |
| 16 |
21122357 | [The effect of bortezomib on migration of endothelial cells and angiogenesis]. | 2010 Jun |
3 |
| 17 |
19331127 | Bortezomib therapeutic effect is associated with expression of FGFR3 in multiple myeloma cells. | 2009 Jan |
1 |
| 18 |
19372569 | Curcumin circumvents chemoresistance in vitro and potentiates the effect of thalidomide and bortezomib against human multiple myeloma in nude mice model. | 2009 Apr |
1 |
| 19 |
18174379 | Bortezomib inhibits tumor adaptation to hypoxia by stimulating the FIH-mediated repression of hypoxia-inducible factor-1. | 2008 Mar 15 |
2 |
| 20 |
18458152 | Small-molecule inhibition of proteasome and silencing by vascular endothelial cell growth factor-specific siRNA induce additive antitumor activity in multiple myeloma. | 2008 Aug |
1 |
| 21 |
17308115 | Suppression of the hypoxia-inducible factor-1 response in cervical carcinoma xenografts by proteasome inhibitors. | 2007 Feb 15 |
1 |
| 22 |
16397231 | Bortezomib mediates antiangiogenesis in multiple myeloma via direct and indirect effects on endothelial cells. | 2006 Jan 1 |
3 |
| 23 |
15026548 | The proteasome inhibitor bortezomib synergizes with gemcitabine to block the growth of human 253JB-V bladder tumors in vivo. | 2004 Mar |
2 |
| 24 |
15492276 | Caveolin-1 is required for vascular endothelial growth factor-triggered multiple myeloma cell migration and is targeted by bortezomib. | 2004 Oct 15 |
6 |
| 25 |
12538487 | Function of nuclear factor kappaB in pancreatic cancer metastasis. | 2003 Jan |
1 |